
Bitarvy
Can medical advertising create cultural change?
LISTEN TO ARTICLE
0:00/1:34
"Society handled this delicate assignment with remarkable sensitivity and exceptional skill.”
-Yuming Chiu
Director of Marketing, Gilead Sciences
Combatting the stigma around HIV required more than just a new pharmaceutical commercial. It demanded authenticity, sensitivity, and groundbreaking storytelling. This was the mission Gilead Sciences and Digitas Health entrusted to Society when they approached us to produce their transformative Biktarvy campaign. The challenge was unprecedented: create the first major HIV treatment campaign featuring real patients, while navigating the complex regulatory requirements of pharmaceutical advertising and handling deeply personal stories with the care they deserved.
The "Keep Being You" campaign grew from a powerful insight: HIV thrives in division, separating people from their health, from each other, and from their true selves. While today's HIV medicines can help people live long, healthy lives, pervasive stigma and shame often prevent people from seeking treatment. This campaign would need to do more than advertise a medication; it needed to challenge those barriers by showing real people living and thriving with HIV.


Traditional pharmaceutical advertising relies heavily on scripted content and actors portraying patients. Breaking this mold required completely reimagining the production process. Working with directors Aaron and Winston Tao, whose work is rooted in authenticity and whose belief that cinema should be used to better mankind aligned perfectly with the project's goals, we developed an approach that could capture genuine stories while meeting exacting pharmaceutical regulations. The production spanned five cities, with each location requiring multiple shooting days to capture both cinematic campaign elements and authentic documentary moments. We created an environment where real patients felt comfortable sharing their stories – from Chad, a performer who found strength through charitable work, to D'Eva, whose love story challenged stigma and preconceptions, to Dimitri, who turned his diagnosis into a platform for education. Each story required its own unique approach, balanced against the need for consistency across the campaign.





Throughout production, our team coordinated with medical experts, regulatory advisors, and lawyers, ensuring that authentic storytelling never came at the expense of compliance or accuracy. This careful balance paid off: within twelve months of launch, Biktarvy achieved blockbuster status with sales of $1.184 billion, projected to reach $7.369 billion by 2023. More importantly, the campaign created new cultural touchpoints that helped combat stigma and shame around HIV diagnosis, providing hope and connection for the estimated 40% of HIV-positive individuals not currently connected to care. The Biktarvy campaign demonstrates Society's unique ability to handle complex, sensitive projects that require both technical excellence and human understanding.
Treatment
BY THE NUMBERS
CITIES FILMED: 6 DOCUMENTARY FILMING DAYS: 12 PEOPLE LIVING WITH HIV IN US: 1.2 MILLION PERCENTAGE NOT IN CARE: 40% PAGES OF LEGAL GUIDELINES: COUNTLESS FIRST-YEAR SALES: $1.184 BILLION PROJECTED SALES BY 2023: $7.369 BILLION STIGMA REDUCTION: IMMEASURABLE
BUDGET: EMAIL US



Biktarvy
Can medical advertising create cultural change?
LISTEN TO ARTICLE
0:00/1:34
"Society handled this delicate assignment with remarkable sensitivity and exceptional skill.”
-Yuming Chiu
Director of Marketing, Gilead Sciences
Combatting the stigma around HIV required more than just a new pharmaceutical commercial. It demanded authenticity, sensitivity, and groundbreaking storytelling. This was the mission Gilead Sciences and Digitas Health entrusted to Society when they approached us to produce their transformative Biktarvy campaign. The challenge was unprecedented: create the first major HIV treatment campaign featuring real patients, while navigating the complex regulatory requirements of pharmaceutical advertising and handling deeply personal stories with the care they deserved.
The "Keep Being You" campaign grew from a powerful insight: HIV thrives in division, separating people from their health, from each other, and from their true selves. While today's HIV medicines can help people live long, healthy lives, pervasive stigma and shame often prevent people from seeking treatment. This campaign would need to do more than advertise a medication; it needed to challenge those barriers by showing real people living and thriving with HIV.


Traditional pharmaceutical advertising relies heavily on scripted content and actors portraying patients. Breaking this mold required completely reimagining the production process. Working with directors Aaron and Winston Tao, whose work is rooted in authenticity and whose belief that cinema should be used to better mankind aligned perfectly with the project's goals, we developed an approach that could capture genuine stories while meeting exacting pharmaceutical regulations. The production spanned five cities, with each location requiring multiple shooting days to capture both cinematic campaign elements and authentic documentary moments. We created an environment where real patients felt comfortable sharing their stories – from Chad, a performer who found strength through charitable work, to D'Eva, whose love story challenged stigma and preconceptions, to Dimitri, who turned his diagnosis into a platform for education. Each story required its own unique approach, balanced against the need for consistency across the campaign.
Throughout production, our team coordinated with medical experts, regulatory advisors, and lawyers, ensuring that authentic storytelling never came at the expense of compliance or accuracy. This careful balance paid off: within twelve months of launch, Biktarvy achieved blockbuster status with sales of $1.184 billion, projected to reach $7.369 billion by 2023. More importantly, the campaign created new cultural touchpoints that helped combat stigma and shame around HIV diagnosis, providing hope and connection for the estimated 40% of HIV-positive individuals not currently connected to care. The Biktarvy campaign demonstrates Society's unique ability to handle complex, sensitive projects that require both technical excellence and human understanding.
Treatment
BY THE NUMBERS
CITIES FILMED: 6 DOCUMENTARY FILMING DAYS: 12 PEOPLE LIVING WITH HIV IN US: 1.2 MILLION PERCENTAGE NOT IN CARE: 40% PAGES OF LEGAL GUIDELINES: COUNTLESS FIRST-YEAR SALES: $1.184 BILLION PROJECTED SALES BY 2023: $7.369 BILLION STIGMA REDUCTION: IMMEASURABLE
BUDGET: EMAIL US






